Actively Recruiting
Pilot Trial of Homebound Stem Cell Transplantation
Led by Memorial Sloan Kettering Cancer Center · Updated on 2026-02-05
91
Participants Needed
1
Research Sites
574 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
In this study, the investigators plan to see what happens when a person receives care in the home setting. They want to find out if caring for a patient who has been treated with an ASCT in the home setting is feasible. They want to find out what effects good and/or bad this will have on the patient's recovery and treatment after ASCT. Studies in other institutions have shown that providing care in the home setting after ASCT is safe, increases patient satisfaction, and can decrease the risk of infection. It is our hope that this new approach of providing care in the home setting will prove to be a feasible and safe option for patients at Memorial Sloan Kettering Cancer Center (MSK).
CONDITIONS
Official Title
Pilot Trial of Homebound Stem Cell Transplantation
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of Plasma cell dyscrasia
- Treatment plan including Autologous HSCT
- Age between 18 and 80 years
- Appropriate homebound setting defined as:
- Lodging at the MSK Residence, or
- Staying at home or a "home equivalent" within specified zip codes passing the Home Environment Screening Tool
- Adequate caregiver support with one or more informal caregivers able to provide 24/7 supervision and complete transplant caregiver education
- Access to Wi-Fi connection
- Appropriate third party payer coverage for Homebound Stem Cell Transplant Program
- Both patient and caregiver willing and able to give informed consent
You will not qualify if you...
- Active infection of grade 3 or higher (viral, bacterial, or fungal) before starting preparative regimen
- Uncontrolled arrhythmias
- Active or uncontrolled pulmonary disease
- Karnofsky Performance Scale (KPS) score less than 80
- Sorror Co-morbidity index 4 or greater except for patients with history of resected cancers
- Creatinine clearance less than 50 cc/minute
- Inability of patient or caregiver to speak or read English
- Inadequate housing arrangements
- Inadequate caregiver arrangements
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Memorial Sloan Kettering Cancer Center
New York, New York, United States, 10065
Actively Recruiting
Research Team
H
Heather Landau, MD
CONTACT
S
Sergio Giralt, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
N/A
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
SCREENING
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here